Amy Wehn, Ph.D., is an Executive Director and Distinguished Scientist in Companion Diagnostics at Merck since November 2020, with prior experience as Sr. Director in Companion Diagnostics at Foundation Medicine from September 2018 to October 2020. At Foundation Medicine, Amy led collaborative companion diagnostic programs and oversaw the development of clinical trial assays. Previously, at HTG Molecular Diagnostics, Amy held multiple roles including Director of Pharma Partnerships, where responsibilities included managing alliances for NGS based targeted RNA sequencing in clinical trials, and Senior Manager for immuno-oncology programs. Earlier career positions included Technical Sales Specialist at FUJIFILM Biosciences, Account Manager at STEMCELL Technologies, and Postdoctoral Research Associate at Lineberger Comprehensive Cancer Center. Education includes a Ph.D. in Molecular, Cellular, and Developmental Biology and a BS in Biological Sciences from the University of Pittsburgh.
This person is not in the org chart
This person is not in any teams
This person is not in any offices